Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) — Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will participate in multiple upcoming healthcare conferences being held in February and March.

Guggenheim SMID Cap Biotech Conference

  Format: Fireside chat and 1×1 meetings
  Date/time: Wednesday, February 5 at 10:30 a.m. ET
  Location: New York, NY
  Webcast link: https://wsw.com/webcast/guggen2/gpcr/2003892
     

Leerink Global Healthcare Conference

  Format: Fireside chat and 1×1 meetings
  Date/time: Monday, March 10 at 1:00 p.m. ET
  Location: Miami, FL
  Webcast link: https://wsw.com/webcast/leerink38/gpcr/2218364
     

Jefferies Biotech on the Bay Summit

  Format: 1×1 meetings
  Date: Tuesday, March 11
  Location: Miami, FL
     

The live and archived webcasts of the fireside chats will be accessible from the company’s website at https://ir.structuretx.com/events-presentations/events and replays will be available for 90 days.

About Structure Therapeutics 
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and cardiopulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, Structure Therapeutics has established a robust GPCR-targeted pipeline, featuring multiple wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the scalability limitations of traditional biologic and peptide therapies and be accessible to more patients around the world. For additional information, please visit www.structuretx.com.

Investors:
Danielle Keatley
Structure Therapeutics Inc.
ir@structuretx.com

Media:
Dan Budwick
1AB
Dan@1abmedia.com

Staff

Recent Posts

Atlantis Operating LLC d/b/a The Phoenix Rehabilitation and Nursing Center Issues Notice of Data Security Incident

BROOKLYN, N.Y., Feb. 20, 2025 /PRNewswire/ -- On or about September 19, 2024, Atlantis Operating…

6 hours ago

Palmetto Operating LLC d/b/a Palmetto Subacute Care Center Issues Notice of Data Security Incident

MIAMI, Feb. 20, 2025 /PRNewswire/ -- On or about September 19, 2024, Palmetto Operating LLC d/b/a Palmetto…

6 hours ago

OWL Planners Officially Launches the OWL Planner™, Simplifying Next-of-Kin Preparation and Essential Document Storage

SALT LAKE CITY, Feb. 20, 2025 /PRNewswire/ -- OWL Planners, a Utah-based company, is excited to…

6 hours ago

HHH Acquisition LLC d/b/a The Grove at Valhalla Rehabilitation and Nursing Center Issues Notice of Data Security Incident

VALHALLA, N.Y., Feb. 20, 2025 /PRNewswire/ -- On or about September 19, 2024, HHH Acquisition…

6 hours ago

Danaher Increases Quarterly Dividend

WASHINGTON, Feb. 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of…

6 hours ago

LexisNexis Health Intelligence Paves a Path of Innovation to Help U.S. Life Insurers Improve the Underwriting Process

Digital Health Data Insights are Needed at Scale for Life Insurers to Continue to Reach…

6 hours ago